why choose us

First received: April 06, 2023

Clinical Trial: ICG and SLN Mapping

Study Status: Completed

Recruit Status: RECRUITING

Condition: Breast Cancer

Study Type: INTERVENTIONAL


Official Title: Use of ICG-fluorescent Imaging for Sentinel Lymph Node Mapping in Patients With Breast Cancer

Brief Summary: The purpose of this research study is to assess the feasibility of using a different dye and imaging device, indocyanine green (ICG)-fluorescent imaging through the Asimov Imaging Platform, to perform sentinel lymph node biopsy.Participants in this research study will be undergoing a sentinel lymph node biopsy as part of surgical treatment for breast cancer.Active participation will last through the post-operative visit.

Read more